JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure

This document is the Japan Circulation Society and Japan Heart Failure Society Joint Guideline for the Diagnosis and Treatment of Acute and Chronic Heart Failure, an update of the 2017 version of the guideline.


JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure - cover page
Brand
JCS/JHFS
Category
Other
Document type
Other
Language
Japanese
Pages
47
File format
PDF
File size
1.5 MB
Published
03 November, 2023
Updated
03 November, 2023
MD5 checksum
D5C11A93FFA4E09B8540E3FF51F9379E

About this manual

This is the 2021 focused update of the JCS/JHFS guideline on the diagnosis and treatment of acute and chronic heart failure, revising the 2017 version. It begins with a chapter on definitions and classification, including heart failure types defined by left ventricular ejection fraction (HFrEF, HFpEF, HFmrEF) and by changes in ejection fraction over time (HFrecEF, HFworEF, HFuncEF), followed by a treatment algorithm.

Later chapters cover drug therapy (ivabradine as an If channel inhibitor, ARNI, SGLT2 inhibitors, and drugs for HFrEF), catheter-based treatment of mitral regurgitation with the MitraClip system, comorbid atrial fibrillation and renal failure, transcatheter aortic valve implantation and the Impella pump, and new drugs such as vericiguat and omecamtiv mecarbil. The document also explains how classes of recommendation, evidence levels and Minds grades are used. This manual is written in Japanese.

What's inside

  • Definitions and classification of heart failure
  • LVEF-based classification (HFrEF, HFpEF, HFmrEF)
  • Treatment algorithm
  • Ivabradine (If channel inhibitor)
  • ARNI (angiotensin receptor neprilysin inhibitor)
  • SGLT2 inhibitors
  • MitraClip system for mitral regurgitation
  • Atrial fibrillation and renal failure
  • TAVI and Impella
  • Vericiguat and omecamtiv mecarbil

Frequently asked questions

How does the guideline classify heart failure by LVEF?

It divides heart failure into HFrEF, HFpEF and HFmrEF according to left ventricular ejection fraction, with additional categories for changes in LVEF over time.

What does ARNI stand for?

Angiotensin receptor neprilysin inhibitor.

What does SGLT2 stand for?

Sodium glucose cotransporter 2.

What does TAVI stand for?

Transcatheter aortic valve implantation.

Download PDF (1.5 MB)